Zhan Shi

USPTO Granted Patents = 23 (Patent Applications = 6)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 10)

Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 92(Granted Patents)

Company Filing History:

17 out of 850

Millennium Pharmaceuticals Limited

Years Active: 2007-2019

where 'Filed Patents' based on already Granted Patents

23 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10323018 - Quinazoline and quinoline compounds and uses thereof (2019-06-18),

2. 10144742 - Quinoxaline compounds and uses thereof (2018-12-04),

3. 10081646 - Heterobicyclic sphingosine 1-phosphate analogs (2018-09-25),

4. 9708353 - Heterobicyclic sphingosine 1-phosphate analogs (2017-07-18),

5. 9181191 - Heterobicyclic sphingosine 1-phosphate analogs (2015-11-10),

6. 9062038 - Heteroaryls and uses thereof (2015-06-23),

7. 9035096 - CCR9 inhibitors and methods of use thereof (2015-05-19),

8. 8796314 - Heteroaryls and uses thereof (2014-08-05),

9. 8796271 - Heteroaryls and uses thereof (2014-08-05),

10. 8796268 - Heteroaryls and uses thereof (2014-08-05),

11. 8765746 - Heteroaryls and uses thereof (2014-07-01),

12. 8569543 - CCR9 inhibitors and methods of use thereof (2013-10-29),

13. 8546359 - Bicyclic aryl sphingosine 1-phosphate analogs (2013-10-01),

14. 8349849 - Heterobicyclic sphingosine 1-phosphate analogs (2013-01-08),

15. 8269043 - Bicyclic aryl sphingosine 1-phosphate analogs (2012-09-18),

Title: The Innovation Journey of Inventor Zhan Shi from Concord, MA

Introduction:

Inventor Zhan Shi, based in Concord, MA, has made significant contributions to the field of pharmaceuticals with his innovative patents and groundbreaking research. With 23 patents to his name, Zhan Shi has shown his prowess in developing compounds with potential applications in treating cancer, inflammatory conditions, and autoimmune diseases.

Latest Patents:

Zhan Shi's latest patents include "Quinazoline and quinoline compounds and uses thereof," which focus on compounds that are inhibitors of NAMPT, offering potential treatment options for cancer and autoimmune diseases. Additionally, his work on "Quinoxaline compounds and uses thereof" showcases his dedication to finding solutions for inflammatory conditions and T-cell mediated autoimmune diseases.

Career Highlights:

Zhan Shi has garnered experience and expertise through his work with renowned companies such as Millennium Pharmaceuticals Limited and Biogen Idec MA Inc. His innovative research and patent applications have paved the way for advancements in the pharmaceutical industry, aiming to improve healthcare outcomes for patients worldwide.

Collaborations:

Throughout his career, Zhan Shi has collaborated with esteemed professionals in the field, including coworkers like Paul E Fleming and Geraldine C B Harriman. These collaborations have enhanced the quality of research and development, leading to impactful inventions and patents that have the potential to revolutionize the healthcare landscape.

Conclusion:

In conclusion, Zhan Shi's journey as an inventor in Concord, MA, is marked by his dedication to innovation and his commitment to developing compounds that address critical healthcare needs. His patents stand as a testament to his contributions to the field of pharmaceuticals, offering hope for improved treatments and therapies in the fight against cancer, inflammatory conditions, and autoimmune diseases.

This text is generated by artificial intelligence and may not be accurate.